Abstract:
|
The objective of the study was to develop methodologies and infrastructure in order to quickly survey blood donors in situations where there could be possible exposure to transfusion transmissible pathogens or other potential hazards to the blood supply. The U.S. Food and Drug Administration (FDA) worked with five Blood Collecting Organizations (BCOs), NORC at the University of Chicago, and the American Association of Blood Banks (AABB) to develop sample frames, select samples, and administer web-surveys. This paper describes the general protocol, the response rates and the rapidity of response for two surveys. One survey addressed exposure to ticks and tick-borne infection and the second survey addressed exposure to the Hepatitis E virus.
|